Valuation Vertex Pharmaceuticals Incorporated

Equities

Market Closed - Nasdaq Other stock markets 21:00:00 04/03/2026 GMT			5-day change	1st Jan Change
477.89 ^USD	+0.76%		-1.07%	+5.41%

03-03	Acadia Pharmaceuticals Inc. Appoints Jonathan M. Poole to Board of Directors and Audit Committee, Effective March 3, 2026	CI
03-03	Vertex Pharmaceuticals Incorporated Presents at TD Cowen 46th Annual Health Care Conference, Mar-03-2026 09:10 AM

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Capitalization ¹	55,834	74,127	104,849	103,707	115,026	121,400	-	-
Change	-	32.76%	41.44%	-1.09%	10.91%	5.54%	-	-
Enterprise Value (EV) ¹	48,309	63,349	93,630	97,591	108,418	107,016	102,273	95,187
Change	-	31.13%	47.8%	4.23%	11.09%	-1.29%	-4.43%	-6.93%
P/E ratio	24.4x	22.5x	29.3x	-194x	29.6x	27.2x	24x	21.5x
PBR	5.53x	5.33x	5.96x	6.4x	6.17x	5.36x	4.52x	3.84x
PEG	-	0.5x	3.51x	2x	-0x	1.9x	1.8x	1.9x
Capitalization / Revenue	7.37x	8.3x	10.6x	9.41x	9.58x	9.32x	8.47x	7.68x
EV / Revenue	6.38x	7.09x	9.49x	8.86x	9.03x	8.21x	7.13x	6.02x
EV / EBITDA	10.8x	12.8x	20.6x	108x	19.8x	18.5x	15.1x	12.6x
EV / EBIT	11.1x	13.2x	21.4x	140x	20.6x	19.1x	15.8x	12.9x
EV / FCF	20.1x	16.1x	28.1x	-123x	33.9x	23.1x	19.8x	16.6x
FCF Yield	4.99%	6.2%	3.56%	-0.81%	2.95%	4.33%	5.05%	6.04%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	9.01	12.82	13.89	-2.08	15.32	17.54	19.93	22.18
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	7,574	8,931	9,869	11,020	12,001	13,029	14,337	15,815
EBITDA ¹	4,470	4,941	4,556	902.8	5,473	5,800	6,780	7,555
EBIT ¹	4,344	4,793	4,375	695.6	5,263	5,615	6,470	7,400
Net income ¹	2,342	3,322	3,620	-535.6	3,953	4,496	5,123	5,591
Net Debt ¹	-7,525	-10,778	-11,218	-6,116	-6,608	-14,384	-19,127	-26,213
Reference price ²	219.60	288.78	406.89	402.70	453.36	477.89	477.89	477.89
Nbr of stocks (in thousands)	254,252	256,691	257,683	257,529	253,719	254,034	-	-
Announcement Date	26/01/22	07/02/23	05/02/24	10/02/25	12/02/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
VERTEX PHARMACEUTICALS INCORPORATED	27.24x	8.21x	18.45x	-.--%	121B
ELI LILLY AND COMPANY	29.49x	11.11x	22.31x	0.66%	897B
JOHNSON & JOHNSON	24.97x	6.05x	16.49x	2.16%	591B
ABBVIE INC.	25.65x	6.99x	14.03x	2.93%	418B
ROCHE HOLDING AG	19.12x	4.71x	11.64x	2.8%	368B
ASTRAZENECA PLC	25.48x	5.28x	14.64x	1.65%	313B
NOVARTIS AG	22.17x	5.97x	14.72x	2.69%	312B
MERCK & CO., INC.	28.12x	4.91x	15.36x	2.81%	297B
AMGEN INC.	25.52x	6.45x	11.47x	2.65%	204B
GILEAD SCIENCES, INC.	20.55x	6.25x	11.3x	2.2%	184B
Average	24.83x	6.59x	15.04x	2.06%	370.51B
Weighted average by Cap.	25.51x	7.19x	16.27x	1.96%